Blog
EndoStim Concludes Pre-Submission Meeting with the FDA
Proven leader in medtech joins to drive company commercialization and growth Santa Ana, California, February 1, 2022 – EndoStim, a medical device company developing and commercializing a first-in-class implantable neurostimulation treatment for drug refractory gastroesophageal reflux disease (GERD), announced today that Eric B. Goorno has been appointed as President and Chief Executive Officer. Goorno brings […]
Read more
Eric Goorno, CEO
Proven leader in medtech joins to drive company commercialization and growth Santa Ana, California, February 1, 2022 – EndoStim, a medical device company developing and commercializing a first-in-class implantable neurostimulation treatment for drug refractory gastroesophageal reflux disease (GERD), announced today that Eric B. Goorno has been appointed as President and Chief Executive Officer. Goorno brings […]
Read more
EndoStim Appoints Eric B. Goorno as Chief Executive Officer
EndoStim announced today that Eric B. Goorno has been appointed as President and Chief Executive Officer.
Read more